MODB | ZFIN | Morpholino Index | Advance Search | BLAST Search | About MODB
Search By For Use * as a wildcard character (e.g. "BMP*"). For Tips on search see Search FAQs.
Morpholino Summary
General Information
Morpholino name: SP3016    
Morpholino sequence: CCGGAAGCGTTATCGAGACATTAGA
Find in Genbank
Target name: zgc:55819
Target sequence: (Morpholino Target and ATG)
Search in Genbank Search in Ensembl
CGAGCTATTGGCTGAGCGGAATTTCCGCCTGATTCCGGAAATGGACGTGGCAAGATGACAAGCTCCTGATGTGCTTCCTGTTGTAACTCTTGTTAAACTATCAGCTGTTAGCCGAACCTTACATTGCACAGACTGGATGTAATAGCCGTTTTTTCCAGCTTTGTCTTTCTAATGTCTCGATAACGCTTCCGGGGGCTCAGCGGCGGCGATGCGGCTGTTTTGGCGCTGGTTTTGGGGACTGATTTGTGTCGGGGTGTCTGCAAATCGTGCAGGATCTCCAGTGTTTTCAGATGAGATCCCCTTCAAAATTAAATGGCCAGGGGCAGACTTTACGCTGTCAACGTCAGGAGGCCTGTACAGAGAAGACGACTATGTTATTATGACAACTACAGAAAAAGAAAAGTACAAGTGTTTATTGCCATCTTTGACAAGCAATCTGGATGATGAGGTGAAGGAGTACAGCGGGCCGAGTCCAGCTGCTTTGCTGGAGCCGTTATTCAAACAGAGCAGCTGCTCTTACAGGATTGAGTCATACTGGACCTATGAAGTTTGCCATGGGAAACATGTGCGGCAGTACCACGAGGACAAAGAGACAGGGCAGAAAATGAACATTCAAGAATACTATCTGGGGAACATGAATAAAAAAGATGGCGCAGAATCAGAAACAGAAAAATCCAGTGACTCTGAAGCAGAATCGCCAAACACCAACACAGAGATACCAACAAAGAATATAGAGGGTCAGCTGACTCCATACTATCCCGTAGAGATGGGACATGGGACAGAATGCACTCTGAAACAGAATCAACCTCGCTCTACCACAGTGCTGTACGTCTGCCATCCTGAGGCAAAGCATGAGATCCTCACAATCGCTGAGGTCATCACCTGTCAGTATGAAGTGGTGGTGCTCACACCCCTGCTCTGTTCTCATCCCAAATACAGGTTCAAGAGCTCTCCAGTGAATGACATCTTCTGCCAGGCTCTGGGTGGTTCACCTCTCAGACCTCAGAGCCTGTCCCAGATGGAACACGAGCAGGAGGAGCTGCTCAAACCACCCTTCAGCACCAGCAGTGAAAGGGGATCCAGGGAGGACACATCTCCAGTGAAGGAAGAGGCCTATACCTCTACCCATAAGCCCCTGACAGTGGGTGGTCAAGCCCAGGTCACCGTTGGCACTACGCACATCTCCCGTCTGACTGATGAACAGCTGATTAAAGAGTTTCTGAGCGGCTCATACTGTCTGCATGGGGGTGTTGGTTGGTGGAAGTATGAATTCTGTTATGGAAAACATGTTCACCAGTATCATGAGGATAAAGAGCAAGGGAAGAACATCGTGGTGGTGGGCAGCTGGAACACTGAGGATCACATGAACTGGGCCAAGAAGAATGTGGCTCGATCTTATCATCTGAAAGATGATGGAGCACAAAAAGTCAAGGTTGTGTCTCACTTCTATGGACATGGAGATCTTTGTGACCTAACAGGGAAACCGAGACAGGTTATAGTCAAGCTAAAGTGTAAGGAGTCTGAATCCCCTCATGCTGTTACAGTGTACATGCTGGAGCCTCAGACATGTCAGTATATCCTCGGGGTTGAGTCACCTGTAATCTGCAAGATCTTGGACACTGCGGATGAAAATGGACTTCTTTCAATTCCTAGCTAGTCTACATGACAAGGAGATGAAGGAATGAACAGCAACTTGGAGAAGGAGGAGTACAGAAGAGGAAGGCAGAATGAAGCTCAGAGGGAGAACTAAAGGTGTGATGACGTTTAGGCATGAACCTGCTGAACCTCAGAGCTGTTGAGAAAGTCCCTCACTGACTGCACTTTCACGTGTTTGACGATTAAACAAGGAGGAGATTTGATGAAACTACTTTTTTATTTTGCGCAGCGTGGACTGAATTTTCCAATGTTTTCTTTTCAAATCTCAGACTTGAGGAAATATGCTTTGACACATTTAGATTGGCTTTGGGAAGGTCTTCTGTTCTTAATTTCATCAAGTGCTTCATTTATTCTATTAATTAAAAAAGGCAGCTCTGCCGTTTTAAATATACATTATTTATTTGGTCAAACTTCTGGTCGTTCAATGGTCAACACTGAGCAGCCAGAGATGATTTTAAAAATTGAAGTAATTGTTCTTATGCAGTTTGTGAGGGAGAATACACTGTTTTGTTTGCAAAGAAACGTGAATGTAATTAAATAGTTTTTTGAAAATCCAGGTTCATGGAGTCTTATGTTTGGTATTTTGAATTATTTCGGCTTAAATTTAACCGCTTATTCTAGGTTGTGTATTATTAAGGTTTCCGCCAGAAAGCTTCACCTTACTGTACAAAAATGAATAATTTAACTCTGAGAACAAATATATTTGGACACCCCTGTATTAAGATAGATTATTTTTTTATAGGTTGGTTGTTGTTCAGCCTGTATATGTTCAGTTGAATAAAATATGAGTTTTGTGTTTCATTCT
Gene targeted:
zgc:55819
Find in ZFIN Find in Pubmed
All the morpholinos targets to the gene
Synonyms:
Comments:
Reference:

Survival Curve: Normality Curve:
Note: When more than one data point existed per dose an average was used. p53 morpholino co-injections were used to minimize non-specific toxicity effects (Robu et al. PLoS Genetics 2007)
Screens Performed (number of tests): Defects Observed:
Blood: (1)
PAX2: (1)
Kidney: (3)
Toxicity: (8)
none: (1)
Pigment: (9)
Eye: (7)
Morphology: (10)
Vasculature: (10)
- dorsal aorta [proposed pooling]
(14.29%, dose:3ng, p53:4.5ng, days: -)
- eye small size
(10%, dose:3ng, p53:4.5ng, days: -)
- eye absent
(10%, dose:4.5ng, p53:6.75ng, days: -)
- eye dysplastic
(35%, dose:4.5ng, p53:6.75ng, days: -)
- eye small size
(50%, dose:4.5ng, p53:6.75ng, days: -)
- iridophores decreased number
(35%, dose:4.5ng, p53:6.75ng, days: -)
- head count
(4%, dose:4.5ng, p53:6.75ng, days: -)
- eye absent
(90%, dose:6ng, p53:9ng, days: -)
- eye dysplastic
(90%, dose:6ng, p53:9ng, days: -)
- eye small size
(80%, dose:6ng, p53:9ng, days: -)
- iridophores decreased number
(90%, dose:6ng, p53:9ng, days: -)
- head count
(3.23%, dose:6ng, p53:9ng, days: -)

Images